COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell?
Cencora Launches Enhanced Nucleus Solution for Specialty Practices
Bet on 5 Top-Ranked Stocks With Rising P/E for Solid Returns
Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns
Cencora Launches Next-Generation Nucleus® Solution with Multi-Site Pilot Across Specialty Physician Practices
Cencora Announces Samantha Hammock as Chief Human Resources Officer
2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now
Cencora's Specialty Supply Chain: Where COR's Growth Is Headed
Cencora (COR) Up 5.7% Since Last Earnings Report: Can It Continue?
Wall Street Analysts Predict a 33.55% Upside in Cencora (COR): Here's What You Should Know
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR
Cencora to Support U.S. Distribution of Kite's CAR T-Cell Therapies
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR
CAH vs. COR: Which Healthcare Distributor Stock Is the Better Buy?
Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR
Cencora Inc (COR) Stock Up 3.6% and Still Undervalued -- GF Score: 79/100
Cencora revises forecast for 2026, approves $2 billion share buyback
Cencora Announces Updated Fiscal Year 2026 Financial Outlook
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR
COR Investors Have Opportunity to Join Cencora, Inc. Fraud Investigation with the Schall Law Firm
Rosen Law Firm Encourages Cencora, Inc. Investors to Inquire About Securities Class Action Investigation – COR
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR
Cencora, Inc. (COR) Presents at BofA Securities 2026 China Conference Transcript
Cencora, Inc. (COR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Why Cencora (COR) is a Top Growth Stock for the Long-Term
Securities Fraud Investigation Into Cencora, Inc. (COR) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?
Cencora, Inc. (COR) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Cencora Q2 Earnings Call Highlights
Securities Fraud Investigation Into Cencora, Inc. (COR) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Cencora Earnings Review: The Selloff Was Overdone In My View
Cencora, Inc. (COR) Q2 2026 Earnings Call Transcript
Why Is Cencora Stock Trading Lower On Wednesday?
COR Stock Falls on Q2 Earnings & Revenue Miss, FY26 EPS View Raised
Cencora (COR) Misses Q2 Earnings and Revenue Estimates
Cencora raises annual profit forecast despite quarterly miss
Cencora Reports Fiscal 2026 Second Quarter Results
Cencora to Report Q2 Earnings: What's in Store for the Stock?
CON vs. COR: Which Stock Is the Better Value Option?
Seeking Clues to Cencora (COR) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Cencora (COR) Reports Next Week: Wall Street Expects Earnings Growth
CareDx (CDNA) Q1 Earnings and Revenues Top Estimates
William Blair Initiates Cardinal Health at Outperform: Is the Pharma Distributor a Stealth Compounder?
CareMetx Acquires U.S.-based Patient Services and Free Goods Pharmacy Operations from Cencora, Significantly Expanding Its Patient Access Platform
Why Congress Can't Stop Loading Up on These 3 Stocks in 2026
Cencora, Inc. $COR Shares Acquired by Assetmark Inc.